Literature DB >> 15194796

E1 empty set E4 protein of human papillomavirus type 16 associates with mitochondria.

Kenneth Raj1, Samuel Berguerand, Shirley Southern, John Doorbar, Peter Beard.   

Abstract

The human papillomavirus (HPV) E1 empty set E4 protein is the most abundantly expressed viral protein in HPV-infected epithelia. It possesses diverse activities, including the ability to bind to the cytokeratin network and to DEAD-box proteins, and in some cases induces the collapse of the former. E1 empty set E4 is also able to prevent the progression of cells into mitosis by arresting them in the G(2) phase of the cell cycle. In spite of these intriguing properties, the role of this protein in the life cycle of the virus is not clear. Here we report that after binding to and collapsing the cytokeratin network, the HPV type 16 E1 empty set E4 protein binds to mitochondria. When cytokeratin is not present in the cell, E1 empty set E4 appears associated with mitochondria soon after its synthesis. The leucine cluster within the N-terminal portion of the E1 empty set E4 protein is pivotal in mediating this association. After the initial binding to mitochondria, the E1 empty set E4 protein induces the detachment of mitochondria from microtubules, causing the organelles to form a single large cluster adjacent to the nucleus. This is followed by a severe reduction in the mitochondrial membrane potential and an induction of apoptosis. HPV DNA replication and virion production occur in terminally differentiating cells which are keratin-rich, rigid squamae that exfoliate after completion of the differentiation process. Perturbation of the cytokeratin network and the eventual induction of apoptotic properties are processes that could render these unyielding cells more fragile and ease the exit of newly synthesized HPVs for subsequent rounds of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194796      PMCID: PMC421641          DOI: 10.1128/JVI.78.13.7199-7207.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  The human papillomavirus E6 protein and its contribution to malignant progression.

Authors:  F Mantovani; L Banks
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

Review 2.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.

Authors:  K Münger; J R Basile; S Duensing; A Eichten; S L Gonzalez; M Grace; V L Zacny
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

3.  The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.

Authors:  K Webster; J Parish; M Pandya; P L Stern; A R Clarke; K Gaston
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts.

Authors:  Annika Antonsson; Bengt Göran Hansson
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Association of the human papillomavirus type 11 E1()E4 protein with cornified cell envelopes derived from infected genital epithelium.

Authors:  J T Bryan; D R Brown
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

6.  Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation.

Authors:  L Eckhart; W Declercq; J Ban; M Rendl; B Lengauer; C Mayer; S Lippens; P Vandenabeele; E Tschachler
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

7.  The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus.

Authors:  J Doorbar; R C Elston; S Napthine; K Raj; E Medcalf; D Jackson; N Coleman; H M Griffin; P Masterson; S Stacey; Y Mengistu; J Dunlop
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Immunolocalization of cytoplasmic dynein and dynactin subunits in cultured macrophages: enrichment on early endocytic organelles.

Authors:  A Habermann; T A Schroer; G Griffiths; J K Burkhardt
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

9.  Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16.

Authors:  Clare E Davy; Deborah J Jackson; Qian Wang; Kenneth Raj; Phillip J Masterson; Nicola F Fenner; Shirley Southern; Scott Cuthill; Jonathan B A Millar; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1.

Authors:  K Egawa; A Iftner; J Doorbar; Y Honda; T Iftner
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

View more
  26 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 2.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

Authors:  D M D'Agostino; M Silic-Benussi; H Hiraragi; M D Lairmore; V Ciminale
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1--E4 protein and provides a molecular basis for its accumulation.

Authors:  Pauline B McIntosh; Stephen R Martin; Deborah J Jackson; Jameela Khan; Erin R Isaacson; Lesley Calder; Kenneth Raj; Heather M Griffin; Qian Wang; Peter Laskey; John F Eccleston; John Doorbar
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.

Authors:  Qingming Ding; Lili Li; Peter Whyte
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

7.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.

Authors:  Ian Bell; Ashley Martin; Sally Roberts
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

9.  Identification of an arginine-rich motif in human papillomavirus type 1 E1;E4 protein necessary for E4-mediated inhibition of cellular DNA synthesis in vitro and in cells.

Authors:  Sally Roberts; Sarah R Kingsbury; Kai Stoeber; Gillian L Knight; Phillip H Gallimore; Gareth H Williams
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

10.  Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.

Authors:  Clare E Davy; Deborah J Jackson; Kenneth Raj; Woei Ling Peh; Shirley A Southern; Papia Das; Rina Sorathia; Peter Laskey; Kate Middleton; Tomomi Nakahara; Qian Wang; Phillip J Masterson; Paul F Lambert; Scott Cuthill; Jonathan B A Millar; John Doorbar
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.